Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'

Detalles Bibliográficos
Autores principales: Ho-Yen, C, Bowen, R L, Kermorgant, S, Jones, J L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670484/
https://www.ncbi.nlm.nih.gov/pubmed/23674084
http://dx.doi.org/10.1038/bjc.2013.249
_version_ 1782271855892103168
author Ho-Yen, C
Bowen, R L
Kermorgant, S
Jones, J L
author_facet Ho-Yen, C
Bowen, R L
Kermorgant, S
Jones, J L
author_sort Ho-Yen, C
collection PubMed
description
format Online
Article
Text
id pubmed-3670484
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36704842014-05-28 Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer' Ho-Yen, C Bowen, R L Kermorgant, S Jones, J L Br J Cancer Letter to the Editor Nature Publishing Group 2013-05-28 2013-05-14 /pmc/articles/PMC3670484/ /pubmed/23674084 http://dx.doi.org/10.1038/bjc.2013.249 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Letter to the Editor
Ho-Yen, C
Bowen, R L
Kermorgant, S
Jones, J L
Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'
title Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'
title_full Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'
title_fullStr Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'
title_full_unstemmed Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'
title_short Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'
title_sort comment on ‘high met expression is an adverse prognostic factor in patients with triple-negative breast cancer'
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670484/
https://www.ncbi.nlm.nih.gov/pubmed/23674084
http://dx.doi.org/10.1038/bjc.2013.249
work_keys_str_mv AT hoyenc commentonhighmetexpressionisanadverseprognosticfactorinpatientswithtriplenegativebreastcancer
AT bowenrl commentonhighmetexpressionisanadverseprognosticfactorinpatientswithtriplenegativebreastcancer
AT kermorgants commentonhighmetexpressionisanadverseprognosticfactorinpatientswithtriplenegativebreastcancer
AT jonesjl commentonhighmetexpressionisanadverseprognosticfactorinpatientswithtriplenegativebreastcancer

Ejemplares similares